Change of demografic indicators, legal form of the ownership, the owner share of pharmacist on the capital and economic situation in the community pharmacies resulting from globalization

Ivona Malovecká, Daniela Mináriková, Viliam Foltan

Abstract


The aim of this paper was to determine a demographic situation, the legal form of the ownership, the owner share of a pharmacist in the capital and the economic situation in the community pharmacies of Slovakia. The number of community pharmacies constantly increases (1540 pharmacies in 2012). The legal forms of the ownership in community pharmacies were limited companies (73.6%), a sole proprietor – pharmacists (23.9%), and Joint Stock Companies (1.3%); in the community pharmacy branches there were also limited companies (73.4%), a sole proprietor – pharmacists (26%), Joint Stock Companies (1%). The owner share of the pharmacist in the capital of public pharmacies was 50.4%, and in the community pharmacy branches it was 66%. The financial analysis for the period of 2007–2012 showed decline in Return on Sales (in 2012 to 1.98 %), decrease of liquidity due to the Current Ratio (in 2012 to 1.87) and the Quick Ratio (in 2012 to 1.08), decrease in the Average Collection Period (in 2012 to 53.8 days), a slight increase in the Average Inventory Period (in 2012 to 36.5 days) and the increased Average Payment Period (in 2012 to 86.3 days).


Keywords


community pharmacy; demographical analysis; legal form of the pharmaceutical care provider; owner's share on the capital; financial analysis; profitability; liquidity; efficiency

Full Text:

PDF

References


PGEU. European Community Pharmacy Blueprint. Pharmaceutical Group of European Union. 2012.

Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: A systematic review of pharmacist and consumer views. Health &Place. 2014;29:140–145. doi:10.1186/1471-2458-11-582

Rechel B, Doyle Y, Grundy E, McKee M. How can health systems respond to population ageing? WHO. 2009.

Anell A. Deregulating the pharmacy market: the case of Iceland and Norway. Health Policy. 2005;75(1):9–17.

IPU. Statement from the Irish Pharmacy Union. Irish Pharmacy Union. 2013.

ATKearney. The future of community pharmacy in England. ATKearney; 2012. 28 p.

Executive Agency for Health and Consumers (EAHC). Survey of Chain of Trust Project, under EU Public Health Programme (Grant Agreement Nо. 2009; 11-13).

Vlachynský et al. Corporate finances. Bratislava: Ekonómia; 2009.

Lluch M, Kanavos P. Impact of regulation of Community Pharmacies on efficiency, access and equity. Evidence from the UK and Spain. Health Policy. 2010;95(2-3):245–54. doi: 10.1016/j.healthpol.2009.11.002.

NCPA. 2009 NCPA Digest. National Community Pharmacist Association. 2010.

Grootendorst P, Rocchi M, Segal H. An Economic Analysis of the Impact of Reductions in Generic Drug Rebates on Community Pharmacy in Canada. Toronto: Leslie Dan Faculty of Pharmacy, University of Toronto; 2008. Available from: http://individual. utoronto.ca/grootendorst/pdf/Grootendorst_et_al_Pharmacy_Rebates_Report_Final.pdf.

Institute of Health Information and Statistics. Health Yearbook of the Slovak Republic 2000, 2007, 2008, 2009, 2010, 2011, 2012.

Eurostat European commission database [online] [cit. 2013-09-27]. Available from: http://epp.eurostat.ec.europa.eu/statistics_explained/index.hp/Population_structure_and_ageing.

The Trade Register of the Slovak Republic. Available from: http://www.zrsr.sk.

The Commercial Register of the Slovak Republic. Available from: http://www.orsr.sk.

The Statistical Office of the Slovak Republic. Available from: http://portal.statistics.sk/showdoc.do?docid=2213.

Szalay T, Pazitny P, Szalayova A, Frisova S, Morvay K, Petrovic M, Ginneken van E. Health system in Transition. Slovakia: Health system review. 2011; 13(2):203.

OECD. Health at a Glance 2009 OECD Indicator. Organisation for Economic Co-operation and Development; 2010.

Eurostat. Database number of inhabitants in 2012. Available from: http://ec.europa.eu/eurostat/tgm/table.do?tab=table&language=en&pcode=tps00001&tableSelection=1&footnotes=yes&labeling=labels&plugin=1

PGEU. Annual report 2013. Available from: http://www.pgeu.eu/en/library/224-annual-report-2013.html

Jackson RA. History of the digest. Available from: http://www.ncpa.co/pdf/digesthistory.pdf

NCPA. NCPA DIGEST 2009. Available from: http://www.ncpanet.org/pdf/digest/digest09_financials.pdf


GOST Style Citations


1. PGEU. European Community Pharmacy Blueprint. Pharmaceutical Group of European Union. 2012.

2. Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: A systematic review of pharmacist and consumer views. Health &Place. 2014;29:140–145. doi:10.1186/1471-2458-11-582

3. Rechel B, Doyle Y, Grundy E, McKee M. How can health systems respond to population ageing? WHO. 2009.

4. Anell A. Deregulating the pharmacy market: the case of Iceland and Norway. Health Policy. 2005;75(1):9–17.

5. IPU. Statement from the Irish Pharmacy Union. Irish Pharmacy Union. 2013.

6. ATKearney. The future of community pharmacy in England. ATKearney; 2012. 28 p.

7. Executive Agency for Health and Consumers (EAHC). Survey of Chain of Trust Project, under EU Public Health Programme (Grant Agreement Nо. 2009; 11-13).

8. Vlachynský et al. Corporate finances. Bratislava: Ekonómia; 2009.

9. Lluch M, Kanavos P. Impact of regulation of Community Pharmacies on efficiency, access and equity. Evidence from the UK and Spain. Health Policy. 2010;95(2-3):245–54. doi: 10.1016/j.healthpol.2009.11.002.

10. NCPA. 2009 NCPA Digest. National Community Pharmacist Association. 2010.

11. Grootendorst P, Rocchi M, Segal H. An Economic Analysis of the Impact of Reductions in Generic Drug Rebates on Community Pharmacy in Canada. Toronto: Leslie Dan Faculty of Pharmacy, University of Toronto; 2008. Available from: http://individual. utoronto.ca/grootendorst/pdf/Grootendorst_et_al_Pharmacy_Rebates_Report_Final.pdf.

12. Institute of Health Information and Statistics. Health Yearbook of the Slovak Republic 2000, 2007, 2008, 2009, 2010, 2011, 2012.

13. Eurostat European commission database [online] [cit. 2013-09-27]. Available from: http://epp.eurostat.ec.europa.eu/statistics_explained/index.hp/Population_structure_and_ageing.

14. The Trade Register of the Slovak Republic. Available from: http://www.zrsr.sk.

15. The Commercial Register of the Slovak Republic. Available from: http://www.orsr.sk.

16. The Statistical Office of the Slovak Republic. Available from: http://portal.statistics.sk/showdoc.do?docid=2213.

17. Szalay T, Pazitny P, Szalayova A, Frisova S, Morvay K, Petrovic M, Ginneken van E. Health system in Transition. Slovakia: Health system review. 2011; 13(2):203.

18. OECD. Health at a Glance 2009 OECD Indicator. Organisation for Economic Co-operation and Development; 2010.

19. Eurostat. Database number of inhabitants in 2012. Available from: http://ec.europa.eu/eurostat/tgm/table.do?tab=table&language=en&pcode=tps00001&tableSelection=1&footnotes=yes&labeling=labels&plugin=1

20. PGEU. Annual report 2013. Available from: http://www.pgeu.eu/en/library/224-annual-report-2013.html

21. Jackson RA. History of the digest. Available from: http://www.ncpa.co/pdf/digesthistory.pdf

22. NCPA. NCPA DIGEST 2009. Available from: http://www.ncpanet.org/pdf/digest/digest09_financials.pdf





DOI: https://doi.org/10.24959/sphhcj.15.5

Abbreviated key title: Soc. farm. ohor. zdor.

ISSN 2518-1564 (Online), ISSN 2413-6085 (Print)